On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property. The license is subject to a research use limited label. 

Under the term of the agreement, SMOC will combine the Broad's CRISPR-Cas9 technology with its own high-throughput production capacity, to enable the development of customized animal models in a unprecedentedly fast and cost-efficient manner.